Compare
Syra Health Corp vs Baiya International Group Inc. vs GEE Group Inc.
| Latest fiscal year | Syra Health Corp SYRA | Baiya International Group Inc. BIYA | GEE Group Inc. JOB |
|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-09-30 |
| Revenue | $7.23M | $16.48M | $96.50M |
| Revenue growth (YoY) | -9.5% | +28.6% | -9.8% |
| Gross margin | 34.4% | 11.5% | 34.6% |
| Operating margin | -12.5% | -58.1% | -26.2% |
| Net margin | -12.4% | -57.8% | -36.0% |
| Net income | -$896.3K | -$9.53M | -$34.75M |
| EPS (Diluted) | -$0.08 | -$5.04 | -$0.32 |
| Operating cash flow | -$447.7K | -$7.44M | $549.0K |
| Free cash flow | -$447.9K | -$7.44M | $533.0K |
| Cash & equivalents | $1.61M | $688.9K | n/a |
| Total assets | $2.77M | $27.83M | $60.00M |
| Total liabilities | $674.7K | $4.76M | $9.99M |
| Shareholders' equity | $2.10M | $23.07M | $50.01M |
| Return on year-end equity | -42.7% | -41.3% | -69.5% |
| Shares outstanding | n/a | n/a | 109.41M |
Revenue, most recent five fiscal years
| Fiscal year | Syra Health Corp | Baiya International Group Inc. | GEE Group Inc. |
|---|---|---|---|
| Latest | $7.23M Ended 2025-12-31 | $16.48M Ended 2025-12-31 | $96.50M Ended 2025-09-30 |
| 1 year earlier | $7.98M Ended 2024-12-31 | $12.81M Ended 2024-12-31 | $106.94M Ended 2024-09-30 |
| 2 years earlier | $5.52M Ended 2023-12-31 | $11.57M Ended 2023-12-31 | $152.44M Ended 2023-09-30 |
| 3 years earlier | $5.62M Ended 2022-12-31 | $13.16M Ended 2022-12-31 | $165.11M Ended 2022-09-30 |
| 4 years earlier | n/a | n/a | $148.88M Ended 2021-09-30 |